OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.190
-0.020 (-0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
OncoCyte Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OncoCyte stock have an average target of 4.42, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 101.83% from the current stock price of 2.19.
Analyst Consensus: Buy
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for OncoCyte stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Oct 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Aug 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | May 16, 2024 |
| Needham | Needham | Strong Buy Maintains $3.6 → $4.25 | Strong Buy | Maintains | $3.6 → $4.25 | +94.06% | Apr 24, 2024 |
Financial Forecast
Revenue This Year
505.00K
from 1.50M
Decreased by -66.40%
Revenue Next Year
1.04M
from 505.00K
Increased by 106.34%
EPS This Year
-2.88
from -3.75
EPS Next Year
-1.69
from -2.88
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 525,000 | 1.5M | 7.8M |
| Avg | 505,000 | 1.0M | 5.8M |
| Low | 490,000 | 584,080 | 3.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -65.1% | 191.1% | 645.7% |
| Avg | -66.4% | 106.3% | 452.5% |
| Low | -67.4% | 15.7% | 276.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.86 | -1.39 | -1.22 |
| Avg | -2.88 | -1.69 | -1.37 |
| Low | -2.92 | -1.85 | -1.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.